Evidence map›Paper›PMID 40059157›Full record

ReviewJournal of nanobiotechnology2025

Recent advances and challenges in metal-based antimicrobial materials: a review of strategies to combat antibiotic resistance.

Chuanda Zhu, Zhenli Diao, Yuanyuan Yang, Jun Liao, Chao Wang, Yanglonghao Li, Zichao Liang, Pengcheng Xu, Xinyu Liu, Qiang Zhang and 4 more

Abstract readReview
In one paragraph

Review in Journal of nanobiotechnology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Nanozyme-based therapeutic strategies for traumatic brain injury.International journal of pharmaceutics: X · 2026
    Review
  2. Review
  3. Review
  4. Targeting multidrug-resistantMaterials today. Bio · 2026
    Article
  5. Review
  6. Article
  7. Review
  8. Review
  9. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

14 authors.

Chuanda Zhu *School of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Zhenli Diao *Department of Clinical Laboratory, Beijing Chao-Yang Hospital, Capital Medical University, Beijing, 100043, China.
Yuanyuan YangSchool of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Jun LiaoSchool of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Chao WangSchool of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Yanglonghao LiSchool of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Zichao LiangSchool of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China.
Pengcheng XuSchool of Pharmaceutical Sciences, Inner Mongolia Medical University, Hohhot, 010110, China.
Xinyu LiuBeijing Life Science Academy, Beijing, 102200, China.
Qiang ZhangSchool of Pharmaceutical Sciences, Peking University, Beijing, 100191, China.
Lidong GongSchool of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China. gld.pku@bjmu.edu.cn.
Qiang MaSchool of Basic Medical Sciences, North China University of Science and Technology, Tangshan City, 063210, Hebei Province, China. qiangma4704@ncst.edu.cn.
Ling LiangSchool of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China. liangling@hsc.pku.edu.cn.
Zhiqiang LinSchool of Basic Medical Sciences, Peking University Health Science Center, Beijing, 100191, China. zhiqiang_lin@bjmu.edu.cn.

Funding

Beijing Natural Science Foundation JQ21038Innovation Fund for Outstanding Doctoral Candidates of Peking University Health Science Center BMU2024BSS001National Natural Science Foundation of China 22378004National Natural Science Foundation of China 32171224National Natural Science Foundation of China U20A20412Postdoctoral Fellowship Program of CPSF GZC20230162
6 · The paper itself

Abstract

Despite the availability of a series of classical antibiotic drugs, bacterial infections continue to represent a significant and urgent threat to global human health. The emergence of drug-resistant bacteria and the slow pace of antibiotic development have rendered current treatment methods inadequate in meeting the clinical demands of bacterial infections. Consequently, there is an increasingly urgent and vital need for the development of safe, efficient, and alternative novel antimicrobial agents in the medical and healthcare field. Over the past five years, there has been a notable expansion in the field of nanomedicine with regard to the prevention and control of infectious diseases. The objective of this article is to provide a comprehensive review of the latest research developments in the field of metal nanomaterials for medical antimicrobial therapy. We begin by delineating the gravity of the bacterial infection crisis, subsequently undertaking a comprehensive examination of the potential mechanisms through which nanoparticles may combat bacterial infections and the specific applications of these nanomaterials in the treatment of diverse infectious diseases. In conclusion, we eagerly anticipate the future development directions of metal nanomaterials in the field of antimicrobial therapy. We believe that with continuous technological advancements and innovations, this field will make even more outstanding contributions to safeguarding human health and well-being.

Indexed as

Anti-Bacterial AgentsAnti-Infective AgentsDrug Resistance, BacterialDrug Resistance, MicrobialMetal NanoparticlesMetalsAnimalsBacteriaBacterial InfectionsHumansNanomedicineAnti-Bacterial AgentsAnti-Infective AgentsMetalsAntibiotic resistanceBacterial infectionsMetallic nanoparticles

Identifiers

PMID40059157
PMCPMC11892188

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.